Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 3,900 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 3,900 shares of the stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $22.60, for a total transaction of $88,140.00. Following the transaction, the insider directly owned 2,208,307 shares in the company, valued at $49,907,738.20. The trade was a 0.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.62, for a total value of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total value of $463,866.76.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Up 0.8%

SI stock opened at $22.24 on Tuesday. The firm has a market cap of $463.02 million and a price-to-earnings ratio of -11.58. Shoulder Innovations, Inc. has a 1-year low of $10.92 and a 1-year high of $24.59. The firm has a fifty day moving average price of $21.03 and a two-hundred day moving average price of $16.60. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92.

Shoulder Innovations (NYSE:SI) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%.The business had revenue of $17.18 million during the quarter. Research analysts predict that Shoulder Innovations, Inc. will post -1.9 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. UBS Group upped their target price on Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, August 10th. Weiss Ratings upgraded Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. Piper Sandler restated an “overweight” rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Finally, BTIG Research increased their target price on Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $25.50.

Hedge Funds Weigh In On Shoulder Innovations

Several hedge funds and other institutional investors have recently made changes to their positions in SI. Sectoral Asset Management Inc. grew its holdings in Shoulder Innovations by 14.4% in the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after buying an additional 62,153 shares in the last quarter. Deerfield Management Company L.P. bought a new stake in Shoulder Innovations during the 3rd quarter valued at $6,056,000. Alyeska Investment Group L.P. acquired a new position in Shoulder Innovations during the 3rd quarter worth $5,667,000. Roubaix Capital LLC boosted its position in Shoulder Innovations by 61.9% during the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares during the period. Finally, Vanguard Group Inc. bought a new position in shares of Shoulder Innovations in the third quarter worth $1,836,000.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.